Eicosapentaenoic Acid Market by Source, Application

Description

List of Tables

[194 Pages Report] The Eicosapentaenoic Acid Market size was estimated at USD 854.68 million in 2023 and expected to reach USD 901.49 million in 2024, at a CAGR 4.55% to reach USD 1,167.25 million by 2030.

Global Eicosapentaenoic Acid Market

KEY MARKET STATISTICS
Base Year [2023]	USD 854.68 million
Estimated Year [2024]	USD 901.49 million
Forecast Year [2030]	USD 1,167.25 million
CAGR (%)	4.55%

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Eicosapentaenoic Acid Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Eicosapentaenoic Acid Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Eicosapentaenoic Acid Market, highlighting leading vendors and their innovative profiles. These include AlgiSys BioSciences Inc, Archer Daniels Midland Company, Arctic Nutrition AG, Asterisk Laboratories (I) Pvt. Ltd., BASF SE, BIOSEARCH, SA, Cayman Chemical Company, Corbion N.V., Croda International PLC, Epax Norway AS, Evonik Industries AG, Golden Omega S.A., Indo Rama Engineers, KD Pharma Group, Koninklijke DSM N.V., Novasep Holding SAS, Novotech Nutraceuticals, Inc., Omega Protein Corporation, Orkla Health AS, Pelagia AS, Santa Cruz Biotechnology, Inc., Shandong Yuwang Pharmaceutical Co., Ltd., SimSon Pharma Limited, Sinomega Biotech Engineering Co.,Ltd, and Toronto Research Chemicals Inc.

Market Segmentation & Coverage

This research report categorizes the Eicosapentaenoic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

Source
- Algae
- Fish
- Krill
Application
- Dietary Supplements
- Functional Food & Beverages
- Pharmaceuticals
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Eicosapentaenoic Acid Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Eicosapentaenoic Acid Market?

3. What are the technology trends and regulatory frameworks in the Eicosapentaenoic Acid Market?

4. What is the market share of the leading vendors in the Eicosapentaenoic Acid Market?

5. Which modes and strategic moves are suitable for entering the Eicosapentaenoic Acid Market?

Product Code: MRR-C002B1C9970B

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Eicosapentaenoic Acid Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Significance of EPA for lowering risk of rising prevalence of chronic diseases
  - 5.1.1.2. Rising health awareness of consumption eicosapentaenoic acids among population
  - 5.1.1.3. Rise in spending on nutritional and infant food products
- 5.1.2. Restraints
  - 5.1.2.1. Issues associated with availability of raw materials required for EPA
- 5.1.3. Opportunities
  - 5.1.3.1. Introduction of sustainable and vegan EPA
  - 5.1.3.2. Rising investments to expand EPA offerings
- 5.1.4. Challenges
  - 5.1.4.1. Possibilities of side effects associated with consumption of EPA
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Eicosapentaenoic Acid Market, by Source

6.1. Introduction
6.2. Algae
6.3. Fish
6.4. Krill

7. Eicosapentaenoic Acid Market, by Application

7.1. Introduction
7.2. Dietary Supplements
7.3. Functional Food & Beverages
7.4. Pharmaceuticals

8. Americas Eicosapentaenoic Acid Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Eicosapentaenoic Acid Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Eicosapentaenoic Acid Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
- 12.1.1. AlgiSys BioSciences Inc
- 12.1.2. Archer Daniels Midland Company
- 12.1.3. Arctic Nutrition AG
- 12.1.4. Asterisk Laboratories (I) Pvt. Ltd.
- 12.1.5. BASF SE
- 12.1.6. BIOSEARCH, SA
- 12.1.7. Cayman Chemical Company
- 12.1.8. Corbion N.V.
- 12.1.9. Croda International PLC
- 12.1.10. Epax Norway AS
- 12.1.11. Evonik Industries AG
- 12.1.12. Golden Omega S.A.
- 12.1.13. Indo Rama Engineers
- 12.1.14. KD Pharma Group
- 12.1.15. Koninklijke DSM N.V.
- 12.1.16. Novasep Holding SAS
- 12.1.17. Novotech Nutraceuticals, Inc.
- 12.1.18. Omega Protein Corporation
- 12.1.19. Orkla Health AS
- 12.1.20. Pelagia AS
- 12.1.21. Santa Cruz Biotechnology, Inc.
- 12.1.22. Shandong Yuwang Pharmaceutical Co., Ltd.
- 12.1.23. SimSon Pharma Limited
- 12.1.24. Sinomega Biotech Engineering Co.,Ltd
- 12.1.25. Toronto Research Chemicals Inc
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing